Arcturus Therapeutics Holdings, Inc. (ARCT)
7.67
+0.47
(+6.53%)
USD |
NASDAQ |
Dec 10, 16:00
7.63
-0.04
(-0.52%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Free Cash Flow: -61.54M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Inovio Pharmaceuticals, Inc. | -89.08M |
| Perspective Therapeutics, Inc. | -106.85M |
| Novavax, Inc. | -384.71M |
| Sangamo Therapeutics, Inc. | -76.40M |
| Myomo, Inc. | -13.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.60M |
| Cash from Investing (Quarterly) | -0.1949M |
| Cash from Financing (Quarterly) | 1.300M |
| Free Cash Flow Per Share (Quarterly) | -0.7282 |
| Free Cash Flow to Equity (Quarterly) | -18.82M |
| Free Cash Flow to Firm (Quarterly) | -19.80M |
| Free Cash Flow Yield | -29.60% |